Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.

Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...